# How Does the Diabetes Drug, Pioglitazone, Reduce Protein Loss in the Urine?

> **NCT00749047** · PHASE4 · UNKNOWN · sponsor: **Christchurch Hospital** · enrollment: 12 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Pioglitazone

## Key facts

- **NCT ID:** NCT00749047
- **Lead sponsor:** Christchurch Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-09
- **Primary completion:** 2009-12
- **Final completion:** 2010-03
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2009-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00749047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00749047, "How Does the Diabetes Drug, Pioglitazone, Reduce Protein Loss in the Urine?". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00749047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*